CANbridge Pharmaceuticals Statistics

Total Valuation

HKG:1228 has a market cap or net worth of HKD 1.55 billion. The enterprise value is 1.49 billion.

Market Cap	1.55B
Enterprise Value	1.49B

Important Dates

The last earnings date was Monday, March 30, 2026.

Earnings Date	Mar 30, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:1228 has 595.44 million shares outstanding. The number of shares has increased by 7.55% in one year.

Current Share Class	595.44M
Shares Outstanding	595.44M
Shares Change (YoY)	+7.55%
Shares Change (QoQ)	+15.09%
Owned by Insiders (%)	7.15%
Owned by Institutions (%)	11.89%
Float	338.30M

Valuation Ratios

The trailing PE ratio is 77.88.

PE Ratio	77.88
Forward PE	n/a
PS Ratio	27.83
PB Ratio	-4.07
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	90.48
EV / Sales	26.82
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.24

Current Ratio	0.24
Quick Ratio	0.18
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-41.57

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-41.06%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	31.97%
Weighted Average Cost of Capital (WACC)	4.93%
Revenue Per Employee	1.36M
Profits Per Employee	402,186
Employee Count	41
Asset Turnover	0.35
Inventory Turnover	0.94

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1,690.54% in the last 52 weeks. The beta is 0.11, so HKG:1228's price volatility has been lower than the market average.

Beta (5Y)	0.11
52-Week Price Change	+1,690.54%
50-Day Moving Average	2.73
200-Day Moving Average	2.12
Relative Strength Index (RSI)	49.68
Average Volume (20 Days)	624,600

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1228 had revenue of HKD 55.62 million and earned 16.49 million in profits. Earnings per share was 0.03.

Revenue	55.62M
Gross Profit	40.68M
Operating Income	-103.16M
Pretax Income	16.49M
Net Income	16.49M
EBITDA	-87.89M
EBIT	-103.16M
Earnings Per Share (EPS)	0.03

Full Income Statement

Balance Sheet

The company has 74.14 million in cash and 17.90 million in debt, with a net cash position of 56.24 million or 0.09 per share.

Cash & Cash Equivalents	74.14M
Total Debt	17.90M
Net Cash	56.24M
Net Cash Per Share	0.09
Equity (Book Value)	-380.31M
Book Value Per Share	-0.79
Working Capital	-384.11M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	15.73M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 73.13%, with operating and profit margins of -185.46% and 29.65%.

Gross Margin	73.13%
Operating Margin	-185.46%
Pretax Margin	29.65%
Profit Margin	29.65%
EBITDA Margin	-158.02%
EBIT Margin	-185.46%
FCF Margin	n/a

Dividends & Yields

HKG:1228 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.55%
Shareholder Yield	-7.55%
Earnings Yield	1.07%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4